0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Morbidity and Mortality Associated With Robotic Head and Neck Surgery An Inquiry of the Food and Drug Administration Manufacturer and User Facility Device Experience Database

Michelle M. Chen, MD1; F. Christopher Holsinger, MD1
[+] Author Affiliations
1Division of Head and Neck Surgery, Department of Otolaryngology, Stanford University, Palo Alto, California
JAMA Otolaryngol Head Neck Surg. 2016;142(4):405-406. doi:10.1001/jamaoto.2015.3673.
Text Size: A A A
Published online

Extract

This review of data from the Food and Drug Administration Manufacturer and User Facility Device Experience Database investigates the rates of morbidity and mortality associated with robotic head and neck surgery since 2009.

Transoral robotic surgery (TORS) using the da Vinci Surgical System (Intuitive Surgical) was first approved for use in otolaryngology by the Food and Drug Administration (FDA) in 2009. With increased adoption of this technology, the head and neck surgical community should continue to evaluate its safety and efficacy.

Figures in this Article

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.
Temporal Trends in Reported Morbidity and Mortality Associated With Use of the da Vinci Surgical System in Otolaryngologic Procedures, 2009 to 2015
Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

260 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();